Study: Alpha Lipoic Acid in Geographic Atrophy
ClinicalTrials.gov Identifier: NCT02613572
ALA: Evaluation of Lipoic Acid as a Treatment for Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD): Phase I- Tolerability Study and Phase II Pilot- Determine the Effects of ALA on the Progression of Geographic Atrophy (GA) in Patients With Age-Related Macular Degeneration (AMD).
Condition: Age-Related Macular Degeneration
Study Type: Interventional
Duration: 72 weeks
For additional information on this study, please click hereBack to Clinical Research